What causes neurofibrillary tangles in cortical neurons?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Neurofibrillary tangles in cortical neurons are primarily caused by the abnormal hyperphosphorylation and misfolding of tau proteins, as supported by the most recent study 1.

Key Factors Contributing to Neurofibrillary Tangle Formation

  • Dysregulation of kinases and phosphatases that control tau phosphorylation
  • Oxidative stress
  • Inflammation
  • Genetic factors
  • Accumulation of beta-amyloid plaques, which may trigger tau pathology through various signaling pathways

Process of Neurofibrillary Tangle Formation

Tau is normally a stabilizing protein that helps maintain the structure of microtubules in neurons. However, when it becomes hyperphosphorylated, it detaches from microtubules and aggregates into paired helical filaments. These filaments then form the characteristic neurofibrillary tangles seen in neurodegenerative diseases like Alzheimer's disease.

Consequences of Neurofibrillary Tangle Formation

Once formed, these tangles disrupt axonal transport, compromise neuronal function, and eventually lead to neuronal death. The process typically begins in the entorhinal cortex and hippocampus before spreading to other brain regions, following a predictable pattern that correlates with cognitive decline in Alzheimer's disease and other tauopathies.

Diagnostic Considerations

The diagnosis of neurofibrillary tangles can be supported by biomarkers such as cerebrospinal fluid (CSF) analysis, which can detect abnormal levels of tau and beta-amyloid proteins 1. Imaging techniques like positron emission tomography (PET) can also be used to visualize amyloid plaques and tau deposits in the brain.

Recent Recommendations

Recent guidelines recommend the use of CSF analysis and imaging techniques like FDG PET to support the diagnosis of Alzheimer's disease and related disorders 1. These guidelines also emphasize the importance of considering the clinical context and using a combination of biomarkers to increase diagnostic accuracy.

Clinical Implications

Understanding the causes and consequences of neurofibrillary tangle formation is crucial for the development of effective therapeutic strategies for Alzheimer's disease and other tauopathies. Early diagnosis and intervention may help slow disease progression and improve patient outcomes.

From the Research

Causes of Neurofibrillary Tangles

  • Neurofibrillary tangles (NFTs) in cortical neurons are primarily composed of hyperphosphorylated tau protein 2, 3, 4.
  • The formation of NFTs is associated with various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP17) 3.
  • Transient cerebral ischemia can induce site-specific hyperphosphorylation of tau protein, leading to the formation of NFTs 3.
  • Abnormally hyperphosphorylated tau protein can accumulate in cortical neurons, contributing to brain damage and potentially leading to neurodegenerative disorders 3, 5.
  • The regional distribution of tau proteins differs among various neurodegenerative disorders, including Alzheimer's disease and amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam 4.

Role of Tau Protein

  • Tau protein is a microtubule-associated protein that plays a crucial role in maintaining microtubule stability 6.
  • Hyperphosphorylation of tau protein leads to its aggregation and the formation of NFTs 2, 3, 4, 6.
  • An imbalance of kinase and phosphatase activities can lead to the abnormal phosphorylation of tau protein 6.

Therapeutic Targets

  • Tau protein is a potential therapeutic target for Alzheimer's disease and related tauopathies 6.
  • Various therapeutic approaches are being developed to target tau protein, including inhibiting tau kinases, enhancing phosphatase activity, promoting microtubule stability, and reducing tau aggregate formation and/or enhancing their clearance 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.